Inoviq Ltd (IIQ)

Sydney
0.510
0.000(0.00%)
  • Volume:
    175,531
  • Bid/Ask:
    0.510/0.530
  • Day's Range:
    0.510 - 0.540

IIQ Overview

Prev. Close
0.51
Day's Range
0.51-0.54
Revenue
420K
Open
0.53
52 wk Range
0.51-2.69
EPS
-0.13
Volume
175,531
Market Cap
46.93M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
192,752
P/E Ratio
-
Beta
-0.63
1-Year Change
-79.07%
Shares Outstanding
92,018,702
Next Earnings Date
-
What is your sentiment on Inoviq?
or
Market is currently closed. Voting is open during market hours.

Inoviq Ltd News

Inoviq Ltd Company Profile

Inoviq Ltd Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. INOVIQ Ltd has a collaboration with The University of Queensland to develop a exosome-based ovarian cancer screening test. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • sale
    0